Stevanato Group SpA
NYSE:STVN

Watchlist Manager
Stevanato Group SpA Logo
Stevanato Group SpA
NYSE:STVN
Watchlist
Price: 19.65 USD 0.15% Market Closed
Market Cap: 5.9B USD
Have any thoughts about
Stevanato Group SpA?
Write Note

Stevanato Group SpA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stevanato Group SpA
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Stevanato Group SpA
NYSE:STVN
Revenue
€1.1B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Revenue
€371m
CAGR 3-Years
24%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

Stevanato Group SpA
Glance View

Market Cap
5.9B USD
Industry
Life Sciences Tools & Services

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 4,652 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.

STVN Intrinsic Value
18.01 USD
Overvaluation 8%
Intrinsic Value
Price

See Also

What is Stevanato Group SpA's Revenue?
Revenue
1.1B EUR

Based on the financial report for Dec 31, 2023, Stevanato Group SpA's Revenue amounts to 1.1B EUR.

What is Stevanato Group SpA's Revenue growth rate?
Revenue CAGR 3Y
18%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Stevanato Group SpA have been 18% over the past three years .

Back to Top